Vitro Diagnostics Inc (VODG) financial statements (2021 and earlier)
Company profile
| Business Address |
4621 TECHNOLOGY DRIVE GOLDEN, CO 80403 |
| State of Incorp. | NV |
| Fiscal Year End | October 31 |
| SIC | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 5 | 3 | 2 | 5 | ||
| Cash and cash equivalents | 5 | 3 | 2 | 5 | ||
| Receivables | 10 | 19 | 2 | |||
| Inventory, net of allowances, customer advances and progress billings | 29 | 22 | 25 | 27 | ||
| Inventory | 29 | 22 | 25 | 27 | ||
| Prepaid expense | 0 | ✕ | ||||
| Other undisclosed current assets | 5 | 3 | 5 | 2 | ||
| Total current assets: | 49 | 47 | 33 | 37 | ||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 44 | 42 | 11 | 17 | ||
| Long-term investments and receivables | 544 | |||||
| Long-term investments | 544 | |||||
| Intangible assets, net (including goodwill) | 12 | 15 | 18 | 21 | ||
| Intangible assets, net (excluding goodwill) | 12 | 15 | 18 | 21 | ||
| Regulated entity, other noncurrent assets | 170 | |||||
| Other noncurrent assets | 1 | ✕ | ||||
| Other undisclosed noncurrent assets | 11 | 1 | (156) | (533) | ||
| Total noncurrent assets: | 67 | 59 | 43 | 49 | ||
| TOTAL ASSETS: | 116 | 106 | 76 | 85 | ||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 1,278 | 1,256 | 28 | |||
| Accounts payable | 64 | 48 | 28 | |||
| Accrued liabilities | 8 | 2 | ||||
| Employee-related liabilities | 1,206 | 1,206 | ||||
| Debt | 8 | 23 | ||||
| Deferred compensation liability | 1,203 | 1,190 | ||||
| Due to related parties | 34 | 30 | ||||
| Other undisclosed current liabilities | 1,174 | 779 | 650 | |||
| Total current liabilities: | 2,495 | 1,309 | 2,010 | 1,840 | ||
| Noncurrent Liabilities | ||||||
| Other undisclosed noncurrent liabilities | 3 | (1,953) | (1,944) | |||
| Total noncurrent liabilities: | 3 | (1,953) | (1,944) | |||
| Other undisclosed liabilities | 957 | |||||
| Total liabilities: | 2,498 | 2,266 | 56 | (104) | ||
| Stockholders' equity | ||||||
| Stockholders' equity attributable to parent, including: | (2,382) | (2,160) | (1,933) | (1,755) | ||
| Common stock | 20 | 20 | 19 | |||
| Additional paid in capital | 5,456 | 5,433 | 5,413 | 5,383 | ||
| Accumulated deficit | (7,859) | (7,613) | (7,366) | (7,155) | ||
| Other undisclosed stockholders' equity attributable to parent | 20 | (1) | ||||
| Stockholders' equity attributable to noncontrolling interest | (1,933) | |||||
| Other undisclosed stockholders' equity | 3,887 | 1,944 | ||||
| Total stockholders' equity: | (2,382) | (2,160) | 20 | 189 | ||
| TOTAL LIABILITIES AND EQUITY: | 116 | 106 | 76 | 85 | ||
Income statement (P&L) ($ in thousands)
| 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|
| Revenues | 78 | 120 | 23 | 28 | |
| Revenue, net | 99 | 95 | 23 | 28 | |
| Cost of revenue (Cost of Goods and Services Sold) | (22) | (23) | (15) | ||
| Other undisclosed gross profit | 7 | (25) | (3) | ||
| Gross profit: | 63 | 72 | 20 | 13 | |
| Operating expenses | (236) | (399) | (229) | (37) | |
| Other undisclosed operating income | 15 | 156 | 58 | ||
| Operating loss: | (158) | (171) | (151) | (24) | |
| Interest and debt expense | (88) | 75 | (60) | ||
| Loss from continuing operations before equity method investments, income taxes: | (246) | (96) | (211) | (24) | |
| Other undisclosed loss from continuing operations before income taxes | (151) | ||||
| Net loss: | (246) | (247) | (211) | (24) | |
| Other undisclosed net loss attributable to parent | (203) | ||||
| Net loss available to common stockholders, diluted: | (246) | (247) | (211) | (228) | |
Comprehensive Income ($ in thousands)
| 10/31/2015 | 10/31/2014 | 10/31/2013 | 10/31/2012 | ||
|---|---|---|---|---|---|
| Net loss: | (246) | (247) | (211) | (24) | |
| Comprehensive loss, net of tax, attributable to parent: | (246) | (247) | (211) | (24) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.